What's new

[Cyprus Times] Coronavirus: the fast-moving virus that prevents transmission. It's not the mask, nor clean hands.

220822211621_stomatiko_dialyma.jpg

An interesting discovery was made by a research team, which found that a product we use in our daily lives could be a powerful ally against the transmission of coronavirus

A surprising conclusion was reached by a research team, which revealed a product of daily use as an important prevention factor against coronavirus. The study, published in Scientific Reports, claims that this product, which takes just 30 seconds to take effect, could be used as a preventive measure to reduce the rate of transmission and progression of SARS-CoV-2 infection.

In particular, the study demonstrated the antiviral activity of cetylpyridinium chloride against the severe acute respiratory syndrome caused by coronavirus.

The virus enters the body through the respiratory epithelium. Scientific evidence, however, shows that it then travels to other areas of the body, such as the oral cavity, where it multiplies and is then released through saliva. Scientific findings have already highlighted an association between SARS-CoV-2 in saliva and exacerbation of COVID-19.

Considering the importance of oral hygiene in SARS-CoV-2 infection and transmission, the researchers wanted to establish the potential antiviral property of oral hygiene products and also how cetylpyridinium chloride acts against SARS-CoV-2 infection.

Cetylpyridinium chloride is an antimicrobial compound commonly found in mouthwashes to prevent bacterial, fungal or viral infections of the oral cavity. It is already known that this compound has antimicrobial properties by breaking down the lipid membrane through physicochemical interactions. Thirty seconds of washing with mouthwash is enough to work effectively, keeping the oral cavity healthy.

Previous studies had expressed the belief that cetylpyridinium chloride is effective against severe SARS-CoV-2 at low concentrations (10-50 μg/ml). This study examined the antiviral effect of cetylpyridinium chloride on a range of SARS-CoV-2 strains, including the main strain and the Alpha, Beta and Gama mutants.

The investigators analyzed oral cavity plaque to examine viral infectivity in the presence and absence of the compound. The concentrations tested were lower than those used in the commercially available oral solution (50 μg/ml). The experts proceeded to infect epithelial cells with the main strain of SARS-CoV-2 that had been exposed to cetylpyridinium chloride in order to verify its effect on virus entry.



The findings revealed that cetylpyridinium chloride at low concentrations (5 - 40 μg/ml) significantly suppressed the infectivity of all tested SARS-CoV-2 strains in a dose-dependent manner. The findings even suggest that it reduces the amount of infectious virus before it enters the host cell.

One factor of interest to the researchers is that human saliva is viscous and contains numerous proteins that could affect the antiviral efficacy of cetylpyridinium chloride. They therefore collected saliva samples from healthy donors, which they mixed with the virus and cetylpyridinium chloride to determine the antiviral efficacy of the compound in saliva.

The findings revealed that cetylpyridinium chloride significantly suppresses virus infectivity even in saliva in a dose-dependent manner.

In a second step, SARS-CoV-2 mixed with cetylpyridinium chloride was subjected to sucrose density analysis and transmission assessment to determine the effect of cetylpyridinium chloride on virus morphology. It was ultimately found to have no effect on the overall structure of the virus, which remained unchanged. The researchers also found that the other components of the mouthwash did not interfere with the action of cetylpyridinium chloride against SARS-CoV-2.

The conclusion of the experts is that cetylpyridinium chloride probably fights SARS-CoV-2 by denaturing the viral proteins and not by disrupting the lipid membrane.

The aim of the study was to highlight the power of cetylpyridinium chloride, even at low concentrations, in inhibiting SARS-CoV-2 and its mutations in rapid time. Scientists are continuing their research in order to draw more and safer conclusions.

Source: ygeiamou.gr


Contents of this article including associated images are belongs Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times

Source
 
Back
Top